MEDX Xelerator

VeinWay is a medical device company focused on developing innovative solutions for the treatment of chronic venous occlusions caused by blockage or disease. The firm's primary offering is a specialized catheter designed to recanalize obstructed veins, providing physicians with a dedicated tool to navigate and clear complicated blockages. By facilitating the restoration of blood flow to the heart, VeinWay aims to transform the management of chronic venous disease and improve patient outcomes. The company's technology not only enables medical professionals to cross previously un-crossable obstructions but also aims to reduce the time required for such procedures.

Exero Medical is a medical device company specializing in early detection systems for gastrointestinal surgery complications. Founded in 2018, it develops biodegradable wireless sensors to monitor anastomotic leaks post-surgery, enabling timely intervention and improved patient outcomes.

Append Medical develops a transcatheter left atrial appendage closure system designed to prevent stroke in atrial fibrillation by eliminating the left atrial appendage through tissue invagination and suture-based closure, offering an alternative to implant-based devices. The system is designed for transfemoral delivery and aims to minimize foreign material at the closure site and reduce device-related thromboembolism risk. The company is in pre-clinical in-vivo testing in its development.

Swift Duct develops a navigational tool for the ERCP procedure, which minimizes the risk of infections in the pancreas.

Synchrony Medical is a clinical stage medical device company focused on the development of LibAirty, an advanced airway clearance system intended for home use. This innovative device aims to assist patients with chronic lung diseases, such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF), in maintaining clear lungs through efficient daily treatments. By enabling remote monitoring and personalized respiratory therapy, Synchrony Medical's solution offers patients a tailored approach to managing their condition, enhancing lung function, and facilitating effective airway clearance.

Dimoveo Medical focuses on developing innovative disinfection technologies aimed at enhancing the safety of medical implants without necessitating their removal from the body. The company’s ultrasound-based system employs ultrasound-accelerated nanoparticles, which are designed to effectively clean in-body surfaces and implants. This advanced technology facilitates the cleaning of implants at high velocities, ensuring that they remain undisturbed while significantly reducing the risk of infection and the need for revision surgeries. Primarily targeting patients undergoing orthopedic procedures, such as knee replacements, Dimoveo Medical's solutions aim to improve patient outcomes and overall surgical protocols.

PatenSee is a clinical-stage medical device company founded in 2019 in Or Yehuda, Central, by Gal Goshen. The company specializes in a contactless surveillance system aimed at detecting early signs of asymptomatic vascular stenosis in hemodialysis patients. Utilizing advanced multi-modal imaging technologies and machine learning, PatenSee's system is designed to seamlessly integrate into clinical workflows. This technology enables healthcare teams to identify early indications of vascular access stenosis, facilitating preventative and cost-effective interventions. By safeguarding the vascular access crucial for hemodialysis, PatenSee aims to enhance patient care and ultimately improve life expectancy for individuals undergoing this treatment.